Article Details

Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer - PipelineReview.com

Retrieved on: 2022-06-03 14:25:28

Tags for this article:

Click the tags to see associated articles and topics

Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer - PipelineReview.com. View article details on hiswai:

Excerpt

Details: Category: Antibodies: Published on Friday, 03 June 2022 15:36 ... Anti-CD39 monoclonal antibody IPH5201 advances to Phase 2 study in lung ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up